• Autologous PRP for alopecia suffers from variability due to patient-specific factors and preparation protocols, hindering consistent clinical outcomes.
• Bioengineered platelet mimetics with defined growth-factor concentrations offer a reproducible alternative to conventional PRP.
• The Precision Re-Engineered Efficacy Optimization framework standardizes potency, composition, and performance of growth-factor formulations.
• Platelet mimetics should be considered controlled reconstructions of selected PRP signals, not full replicas, requiring rigorous characterization and clinical validation.